APOPTOSIS: Silent but deadly

Mitchell, Alison
March 2001
Nature Reviews Molecular Cell Biology;Mar2001, Vol. 2 Issue 3, p163
Academic Journal
Discusses research being done on tumor types for loss-of-function mutations in Apaf-1 tumor-suppressor gene. Reference to a study by Scott W. Lowe et al published in the 2001 issue of "Nature"; Description of Apaf-1; Reason that Apaf-1 is transcriptionally silenced.


Related Articles

  • Tumor Suppressor Gene.  // Encyclopedic Reference of Molecular Pharmacology;2004, p933 

    An encyclopedia entry of the term "tumor suppressor gene" (TSG) is presented. TSG is identified by its loss of mutation functions in tumors. A mutation in only one allele of a tumor suppressor has no phenotype, unless followed by mutation of the second allele. Mutated allele contains a specific...

  • Many Ribosomal Protein Genes Are Cancer Genes in Zebrafish. Amsterdam, Adam; Sadler, Kirsten C.; Lai, Kevin; Farrington, Sarah; Bronson, Roderick T.; Lees, Jacqueline A.; Hopkins, Nancy // PLoS Biology;May2004, Vol. 2 Issue 5, p690 

    We have generated several hundred lines of zebrafish (Danio rerio), each heterozygous for a recessive embryonic lethal mutation. Since many tumor suppressor genes are recessive lethals, we screened our colony for lines that display early mortality and/or gross evidence of tumors. We identified...

  • Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer. Bolton, Kelly L.; Chenevix-Trench, Georgia; Goh, Cindy; Sadetzki, Siegal; Ramus, Susan J.; Karlan, Beth Y; Lambrechts, Diether; Despierre, Evelyn; Barrowdale, Daniel; McGuffog, Lesley; Healey, Sue; Easton, Douglas F.; Sinilnikova, Olga; Benítez, Javier; García, María J.; Neuhausen, Susan; Gail, Mitchell H.; Hartge, Patricia; Peock, Susan; Frost, Debra // JAMA: Journal of the American Medical Association;1/25/2012, Vol. 307 Issue 4, p382 

    The article discusses a study on the relationship of germline mutations in the tumor suppressor genes BRCA1 and BRCA1 with survival in women with invasive epithelial ovarian cancer (EOC). The study found that 5-year overall survival for noncarriers of BRCA1 and BRCA2 was 36% and 44% and 52% for...

  • PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis. Rybanska, I; Ishaq, O; Chou, J; Prakash, M; Bakhsheshian, J; Huso, D L; Franco, S // Oncogene;4/4/2013, Vol. 32 Issue 14, p1761 

    Poly(ADP-ribose) polymerase 1 (PARP1) interacts genetically with the DNA-dependent protein kinase catalytic subunit (DNA-PKcs) to suppress early-onset T-lineage lymphomas in the mouse, but the underlying mechanisms have remained unknown. To address this question, we analyzed a series of...

  • Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples.  // PLoS ONE;2009, Vol. 4 Issue 11, p1 

    The article presents a study related to the profiling of critical cancer gene mutations in clinical tumor samples. An optimized mutation profiling platform was developed and implemented, in order to interrogate 400 mutations in 33 known oncogenes and tumor suppressors. The results indicate that...

  • Mitochondrial and Nuclear Genes of Mitochondrial Components in Cancer. Kirches, E. // Current Genomics;Jun2009, Vol. 10 Issue 4, p281 

    Although the observation of aerobic glycolysis of tumor cells by Otto v. Warburg had demonstrated abnormalities of mitochondrial energy metabolism in cancer decades ago, there was no clear evidence for a functional role of mutant mitochondrial proteins in cancer development until the early years...

  • Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer. K. P. M. Suijkerbuijk; M. J. Fackler; S. Sukumar; C. H. van Gils; T. van Laar; E. van der Wall; M. Vooijs; P. J. van Diest // Annals of Oncology;Nov2008, Vol. 19 Issue 11, p1870 

    Background: Promoter methylation is a common epigenetic mechanism to silence tumor suppressor genes during breast cancer development. We investigated whether BRCA1-associated breast tumors show cancer-predictive methylation patterns similar to those found in sporadic tumors. Patients and...

  • Evidence for a Tumor Suppressor Role for the Large Tumor Suppressor Genes and LATS1 LATS2 in Human Cancer. Tian Yu; Bachman, John; Zhi-Chun Lai // Genetics;Nov2013, Vol. 195 Issue 3, p1193 

    The role of Large tumor suppressor LATS/Warts in human cancer is not clearly understood. Here we show that hLATS1/2 cancer mutations affect their expression and kinase activity. hLATS1/2 mutants exhibit a decreased activity in inhibiting YAP and tissue growth. Therefore, hLATS1/2 alleles from...

  • Early p53 mutations in nondysplastic Barrett's tissue detected by the restriction stie mutation (RSM) methodology. Jenkins, G.J.S.; Doak, S.H.; Griffiths, A.P.; Tofazzal, N.; Shah, V.; Baxter, J.N.; Parry, J.M. // British Journal of Cancer;4/22/2003, Vol. 88 Issue 8, p1271 

    Barrett's oesophagus is a premalignant condition whose incidence is rising dramatically. Molecular markers are urgently needed to identify Barrett's patients at the highest risk of cancer progression. To this end, we have used a rapid molecular technique, restriction site mutation (RSM), to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics